La EFPIA propone chequeos cardiovasculares sistemáticos para reducir la mortalidad prematura en la UE – El Globalfarma

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has proposed the implementation of systematic cardiovascular check-ups across the European Union to combat premature mortality. This initiative aims to standardize how cardiovascular risk is identified and managed across member states to prevent avoidable deaths from heart disease, and stroke.

Cardiovascular diseases remain the leading cause of death in the EU, yet a significant portion of these fatalities are considered preventable through early detection and intervention. The proposal emphasizes that a coordinated, systemic approach to screening would allow healthcare providers to identify high-risk patients before critical events occur.

Standardizing Risk Assessment Across the EU

A central pillar of the EFPIA proposal is the standardization of cardiovascular screenings. Currently, the approach to detecting risk factors varies significantly between different European countries, leading to disparities in patient outcomes and survival rates.

By establishing a uniform protocol for check-ups, the organization argues that the EU can ensure that every citizen, regardless of their location, has access to the same level of preventative care. This standardization would focus on the consistent monitoring of key biomarkers and risk factors that contribute to heart failure and vascular incidents.

The proposal suggests that systematic screenings would move the healthcare model from a reactive approach—treating a patient after a heart attack or stroke—to a proactive model of prevention and early management.

The Critical Role of Primary Care

Medical analysts and public health advocates highlight primary care as the essential engine for reducing cardiovascular mortality. Because primary care physicians are the first point of contact for most patients, they are uniquely positioned to implement the systematic screenings proposed by EFPIA.

Effective primary care intervention involves the regular screening of several critical indicators, including:

• Blood pressure levels to detect and manage hypertension.
• Lipid profiles to identify high cholesterol and other dyslipidemias.
• Blood glucose levels to screen for diabetes, which significantly increases cardiovascular risk.
• Patient history and lifestyle factors, such as smoking status and body mass index.

When these screenings are integrated into routine primary care visits, healthcare providers can initiate pharmacological or lifestyle interventions much earlier, significantly lowering the probability of premature death.

Addressing the Cardiovascular Care Gap

Despite the high mortality rates associated with heart disease, some health observers describe cardiovascular health as the ugly duckling of the healthcare system. This term refers to the tendency of cardiovascular prevention to receive less attention, funding, or systemic urgency compared to other high-profile medical areas, despite its status as a primary driver of death.

The disparity is often seen in the gap between the availability of advanced treatments for acute events and the lack of robust systems for early prevention. While the EU possesses world-class facilities for treating myocardial infarctions, the systemic failure to screen asymptomatic patients leads to a higher number of preventable emergencies.

The EFPIA proposal seeks to close this gap by elevating the status of preventative cardiovascular health to a priority level consistent with its impact on public health.

Public Health Implications and Next Steps

If adopted, a systematic screening program would require a shift in health policy and resource allocation across EU member states. This would involve not only the training of primary care staff but also the integration of digital health records to track risk factors over time.

The goal is to reduce the incidence of premature mortality by catching “silent” killers—such as asymptomatic hypertension or high LDL cholesterol—before they manifest as life-threatening events. By treating these conditions early, the burden on hospital emergency departments and intensive care units could be substantially reduced.

The success of such a program depends on the willingness of EU health ministries to adopt standardized guidelines and provide the necessary infrastructure to support primary care physicians in their screening efforts.